GLP-1s tied to 17% reduction in long-term sick leave: 4 study notes

The study reveals that GLP-1 medications, like Ozempic, are associated with a 17.3% decrease in long-term sick leave over a four-year period, suggesting these drugs may significantly reduce healthcare-related absenteeism. Researchers matched 7,011 patients starting Ozempic with a similar group initiating other treatments, underscoring the potential economic and health benefits of GLP-1s. This finding is crucial as it highlights the broader impact of managing chronic conditions, potentially reducing healthcare costs and improving workforce productivity.